MedTrace Logo

Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)

NCT00562094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8616

Last updated 2012-05-08

Study results available
· View outcomes & findings →

Summary

The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.

Conditions

  • Erosive Gastroesophageal Reflux Disease
  • Non-Erosive Reflux Disease

Interventions

DRUG

Pantoprazole

This was an observational study. Therefore, the physician decided about dosage according to individual needs.

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Dr. Thomas D. Bethke, MD, MBA · Nycomed Deutschland GmbH, 78467 Konstanz, Germany

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00562094 on ClinicalTrials.gov